Edition:
United States

bluebird bio Inc (BLUE.O)

BLUE.O on Nasdaq

129.96USD
18 Jan 2019
Change (% chg)

$3.46 (+2.74%)
Prev Close
$126.50
Open
$127.23
Day's High
$130.77
Day's Low
$125.81
Volume
672,320
Avg. Vol
769,294
52-wk High
$236.17
52-wk Low
$87.49

Chart for

About

bluebird bio, Inc. is a clinical-stage biotechnology company. The Company is focused on developing gene therapies for severe diseases and cancer. With its lentiviral-based gene therapy and gene editing capabilities, it has built an integrated product platform with various applications in these areas. The Company's clinical... (more)

Overall

Beta: 2.34
Market Cap(Mil.): $6,708.27
Shares Outstanding(Mil.): 54.69
Dividend: --
Yield (%): --

Financials

  BLUE.O Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -8.19 -- --
ROI: -23.55 0.60 13.80
ROE: -26.60 -2.18 15.29

Earnings vs. Estimates